GlassScriptPhysician profile
Adam Robert Carr
NPI 1760977169
$4,425.26
in general payments reported to CMS, 2019-2025
20 companies · $1,411 in 2025
The $1,411 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $167 · 2022: $181 · 2023: $2,556 · 2024: $110 · 2025: $1,411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,529 · Food and Beverage: $1,548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,529.13 |
| Food and Beverage | $1,547.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $1,683.69 | 2023 | Gmk Sphere, Amistem |
| Zimmer Biomet Holdings, INC. | $1,387.67 | 2024-2025 | Avenir, Anterior Supine Stem Extractor, Visco-3 Sodium Hyaluronate |
| Stryker Corporation | $485.90 | 2022-2023 | T2 Alpha, Mako, Gamma |
| Smith+Nephew, INC. | $277.26 | 2023 | Healicoil, Bioinductive Implant With Arthroscopic Delivery System - Medium, Firstpass |
| Davol INC. | $137.32 | 2023 | Channel Drain |
| Vericel Corporation | $91.62 | 2021 | |
| Ethicon US, LLC | $67.19 | 2023-2025 | Ethicon, Vistaseal, Stratafix |
| Boston Scientific Corporation | $65.21 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $38.20 | 2023 | Rexulti |
| Ferring Pharmaceuticals INC. | $29.09 | 2023-2024 | Euflexxa |
| Heron Therapeutics, INC. | $25.73 | 2021-2024 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $20.94 | 2023 | Iovera, Zilretta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.83 | 2023 | Tradjenta, Jardiance |
| Olympus America INC. | $16.51 | 2025 | Hd 3cmos Autoclavable Camera Head |
| Astrazeneca Pharmaceuticals LP | $14.57 | 2024 | Farxiga |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $14.31 | 2023 | Xiaflex |
| Bioventus LLC | $13.44 | 2024 | Supartz Fx Sodium Hyaluronate |
| Exact Sciences Corporation | $13.33 | 2023 | Cologuard Collection Kit |
| Medwest Associates | $12.99 | 2023 | |
| Heraeus Medical, LLC. | $10.46 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.